David J. Blanchard

Array ( [id] => 5148260 [patent_doc_number] => 20070048319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'ANTIBODIES THAT BIND BOTH BCMA AND TACI' [patent_app_type] => utility [patent_app_number] => 11/553628 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22781 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048319.pdf [firstpage_image] =>[orig_patent_app_number] => 11553628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4574929 [patent_doc_number] => 07833528 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'Use of multispecific, non-covalent complexes for targeted delivery of therapeutics' [patent_app_type] => utility [patent_app_number] => 11/553814 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11684 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/833/07833528.pdf [firstpage_image] =>[orig_patent_app_number] => 11553814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5148164 [patent_doc_number] => 20070048220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'ANTIBODIES THAT BIND BOTH BCMA AND TACI' [patent_app_type] => utility [patent_app_number] => 11/553622 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22777 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048220.pdf [firstpage_image] =>[orig_patent_app_number] => 11553622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5289984 [patent_doc_number] => 20090022714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist' [patent_app_type] => utility [patent_app_number] => 11/583736 [patent_app_country] => US [patent_app_date] => 2006-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 31501 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20090022714.pdf [firstpage_image] =>[orig_patent_app_number] => 11583736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4608386 [patent_doc_number] => 07993641 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Methods of treatment using anti-CD3 antibodies' [patent_app_type] => utility [patent_app_number] => 11/581008 [patent_app_country] => US [patent_app_date] => 2006-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7756 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/993/07993641.pdf [firstpage_image] =>[orig_patent_app_number] => 11581008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5050885 [patent_doc_number] => 20070031430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Immunoconjugates' [patent_app_type] => utility [patent_app_number] => 11/542714 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7099 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031430.pdf [firstpage_image] =>[orig_patent_app_number] => 11542714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5154372 [patent_doc_number] => 20070037255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'ANTIBODY VARIANTS WITH FASTER ANTIGEN ASSOCIATION RATES' [patent_app_type] => utility [patent_app_number] => 11/537851 [patent_app_country] => US [patent_app_date] => 2006-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21793 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037255.pdf [firstpage_image] =>[orig_patent_app_number] => 11537851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5241767 [patent_doc_number] => 20070020259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'ANTI-CD20 ANTIBODIES AND FUSION PROTEINS THEREOF AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 11/534103 [patent_app_country] => US [patent_app_date] => 2006-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 25795 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020259.pdf [firstpage_image] =>[orig_patent_app_number] => 11534103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5074821 [patent_doc_number] => 20070014796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Method for the production of non-immunogenic proteins' [patent_app_type] => utility [patent_app_number] => 11/516295 [patent_app_country] => US [patent_app_date] => 2006-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 13165 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20070014796.pdf [firstpage_image] =>[orig_patent_app_number] => 11516295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4534827 [patent_doc_number] => 07872102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'Anti-IL-23 antibodies' [patent_app_type] => utility [patent_app_number] => 11/997597 [patent_app_country] => US [patent_app_date] => 2006-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12836 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/872/07872102.pdf [firstpage_image] =>[orig_patent_app_number] => 11997597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5624867 [patent_doc_number] => 20060263372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 11/462092 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11469 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263372.pdf [firstpage_image] =>[orig_patent_app_number] => 11462092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 341744 [patent_doc_number] => 07501502 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-10 [patent_title] => 'Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer' [patent_app_type] => utility [patent_app_number] => 11/489907 [patent_app_country] => US [patent_app_date] => 2006-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 69631 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/501/07501502.pdf [firstpage_image] =>[orig_patent_app_number] => 11489907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4778271 [patent_doc_number] => 20080286269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Anti-alpha(v)beta(6) antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/483190 [patent_app_country] => US [patent_app_date] => 2006-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 80 [patent_figures_cnt] => 80 [patent_no_of_words] => 81840 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286269.pdf [firstpage_image] =>[orig_patent_app_number] => 11483190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4994191 [patent_doc_number] => 20070009536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Novel MAdCAM antibodies' [patent_app_type] => utility [patent_app_number] => 11/484456 [patent_app_country] => US [patent_app_date] => 2006-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20743 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20070009536.pdf [firstpage_image] =>[orig_patent_app_number] => 11484456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921335 [patent_doc_number] => 20060240003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Humanised antibodies to the epidermal growth factor receptor' [patent_app_type] => utility [patent_app_number] => 11/478657 [patent_app_country] => US [patent_app_date] => 2006-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9117 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240003.pdf [firstpage_image] =>[orig_patent_app_number] => 11478657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834247 [patent_doc_number] => 20060246077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Use of antibodies against the MUC18 antigen' [patent_app_type] => utility [patent_app_number] => 11/479339 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 16628 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246077.pdf [firstpage_image] =>[orig_patent_app_number] => 11479339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834717 [patent_doc_number] => 20060246548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'CE7-specific redirected immune cells' [patent_app_type] => utility [patent_app_number] => 11/477572 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15561 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246548.pdf [firstpage_image] =>[orig_patent_app_number] => 11477572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5075236 [patent_doc_number] => 20070015211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Conformer-specific antibodies and method of use, thereof' [patent_app_type] => utility [patent_app_number] => 11/473460 [patent_app_country] => US [patent_app_date] => 2006-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14372 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015211.pdf [firstpage_image] =>[orig_patent_app_number] => 11473460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5852012 [patent_doc_number] => 20060235203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'MN gene and protein' [patent_app_type] => utility [patent_app_number] => 11/448576 [patent_app_country] => US [patent_app_date] => 2006-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 40824 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20060235203.pdf [firstpage_image] =>[orig_patent_app_number] => 11448576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5141769 [patent_doc_number] => 20070003985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Specific mucin expression as a marker for pancreatic cancer' [patent_app_type] => utility [patent_app_number] => 11/444123 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12374 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003985.pdf [firstpage_image] =>[orig_patent_app_number] => 11444123 [rel_patent_id] =>[rel_patent_doc_number] =>)